Secondary Prevention of Atrial Fibrilation

NATerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

May 11, 2020

Study Completion Date

May 11, 2020

Conditions
Atrial FibrillationRisk FactorsRisk Reduction Behavior
Interventions
OTHER

AliveCor mobile ECG cardiac monitor

AliveCor mobile ECG cardiac monitor is capable of providing real-time heart telemetry using a smart phone. Participants will be instructed to transmit rhythm data twice weekly and during symptomatic AF.

BEHAVIORAL

AF Program

The AF program includes a bundle of sub-interventions that target specific AF risk factors including hypertension, obesity, physical inactivity, sleep hygiene, and smoking. Participants randomized to the intervention group 2 will undergo counseling by the nurse and guided through the structured, goal-directed AF program. Each participant will receive an AliveCor cardiac monitor which is capable of providing real-time heart telemetry using a smart phone.

OTHER

Standard of care

Guideline-directed medical therapy according to clinical standard practice at Boston Medical Center.

Trial Locations (1)

02118

Boston Medical Center, Boston

Sponsors
All Listed Sponsors
collaborator

Boston University

OTHER

lead

Boston Medical Center

OTHER

NCT03259893 - Secondary Prevention of Atrial Fibrilation | Biotech Hunter | Biotech Hunter